United States · Funded startup

Who invested in NephroGenex

4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$22Mraised across 4 rounds since 2007, from 4 sources

$3.3MSeries A$1.0MVenture$12MRound$5.5MRound
Latest round
Round, $5.5MNov 2015
Biggest round
$12MRound · Nov 2014
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20072009201120132015
$3.3MSeries A$1.0MVenture$12MRound$5.5MRound
First round
Series A, $3.3M
Jul 2007
Biggest round
$12M
Round · Nov 2014
Usual gap between rounds
3 years
the median of 3

The rounds

  1. Nov 2015
    Round$5.5M

    No investor was named in the report.

    From a historical funding recordSEC filing: $5.5M sold, first sale Nov 2015

  2. Nov 2014
    Round$12M

    No investor was named in the report.

    From a historical funding record

  3. Jul 2010
    Venture$1.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $1.0M sold, first sale Jul 2010

  4. Jul 2007

Founders and team

From NephroGenex's own website: 4 on the team.

  • Pierre LegaultChief Executive Officer and President
  • Bob PetersonVice President of Product Development and Regulatory Affairs
  • Pepper LandsonVice President of Clinical Operations
  • John P. HamillChief Financial Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2007Venture2010Round2014Round2015Care CapitalVanderbilt University Office of InvestmentsBioStratum

Everyone who backed them

Care CapitalGrowth equity1round
BioStratumno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about NephroGenex

Who invested in NephroGenex?

NephroGenex's investors include Care Capital, Vanderbilt University Office of Investments and BioStratum.

How much has NephroGenex raised?

NephroGenex has raised $22M across 4 rounds since 2007.

When did NephroGenex last raise?

NephroGenex's most recent round was an Undisclosed round of $5.5M in Nov 2015.

What was NephroGenex's biggest round?

NephroGenex's largest round on record is $12M (Undisclosed round), in Nov 2014.

Who backed NephroGenex first?

NephroGenex's first round on record, in Jul 2007, was backed by Care Capital, Vanderbilt University Office of Investments and BioStratum.

What stage is NephroGenex at?

NephroGenex's latest named round is an Undisclosed round, in Nov 2015.

Where is NephroGenex based?

NephroGenex is based in the United States.

Companies like NephroGenex

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.